Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Experian slides on worries about US data anlytics firm Fair Isaac's new program

(Sharecast News) - Experian slumped on Thursday after US analytics software firm Fair Isaac announced the launch of a new program that could make US lenders less reliant on credit agencies. Fair Isaac said on Wednesday that the 'FICO® Mortgage Direct License Program' will eliminate reliance on the three nationwide credit bureaus, giving tri-merge resellers the option to calculate and distribute FICO scores directly to their customers.

The news hit shares of Equifax and TransUnion, which closed down 11.1% and 7.1% respectively on Wednesday.

The FICO score is used by lenders to help make credit risk decisions across the customer lifecycle.

A tri-merge credit report - also known as a three-bureau report - combines information from Equifax, Experian and TransUnion into a single report.

Fair Isaac chief executive Will Lansing said: "Today marks a turning point in how credit scores are delivered and priced across the mortgage industry.

"Direct licensing of the FICO Score brings transparency, competition, and cost-efficiency to the mortgage lending process. This change eliminates unnecessary mark-ups on the FICO Score and puts pricing model choice in the hands of those who use FICO Scores to drive mortgage decisions."

At 1025 BST, Experian shares were down 6.6% at 3,431.25p.

Citi said the stated aim of the move is to reduce costs for mortgage providers and the implication is that this would cut out the margin that the likes of Experian and Equifax make on the FICO credit score itself.

"We would expect more information to come out through the day, but our initial reaction is that this is negative for Experian and Equifax," said analyst Arthur Truslove.

Elsewhere, Jefferies said it had assumed it would be at least a couple of years before FICO went direct with pricing, but it appears a combination of regulatory pressure and the high cost of breakage to lenders has forced FICO's hand.

The move is "effectively taking away the ability of the credit bureaus to mark up the FICO score", it said.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.